Format

Send to

Choose Destination
Eur Respir J. 2017 Apr 26;49(4). pii: 1700374. doi: 10.1183/13993003.00374-2017. Print 2017 Apr.

Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs.

Author information

1
Epidemiology Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA rprevots@niaid.nih.gov.
2
German Central Committee against Tuberculosis, Berlin, Germany.
3
Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Sassari, Italy.
4
Director, WHO Collaborating Centre for TB and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy.
PMID:
28446563
DOI:
10.1183/13993003.00374-2017
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center